Tead Proteins Activate the Foxa2 Enhancer in the Node in Cooperation with a Second Factor
Overview
Authors
Affiliations
The cell population and the activity of the organizer change during the course of development. We addressed the mechanism of mouse node development via an analysis of the node/notochord enhancer (NE) of Foxa2. We first identified the core element (CE) of the enhancer, which in multimeric form drives gene expression in the node. The CE was activated in Wnt/beta-catenin-treated P19 cells with a time lag, and this activation was dependent on two separate sequence motifs within the CE. These same motifs were also required for enhancer activity in transgenic embryos. We identified the Tead family of transcription factors as binding proteins for the 3' motif. Teads and their co-factor YAP65 activated the CE in P19 cells, and binding of Tead to CE was essential for enhancer activity. Inhibition of Tead activity by repressor-modified Tead compromised NE enhancer activation and notochord development in transgenic mouse embryos. Furthermore, manipulation of Tead activity in zebrafish embryos led to altered expression of foxa2 in the embryonic shield. These results suggest that Tead activates the Foxa2 enhancer core element in the mouse node in cooperation with a second factor that binds to the 5' element, and that a similar mechanism also operates in the zebrafish shield.
Single-cell Transcriptomic Studies Unveil Potential Nodes of the Notochord Gene Regulatory Network.
Negron-Pineiro L, Di Gregorio A Integr Comp Biol. 2024; 64(5):1194-1213.
PMID: 38914463 PMC: 11579531. DOI: 10.1093/icb/icae084.
TEAD2 initiates ground-state pluripotency by mediating chromatin looping.
Guo R, Dong X, Chen F, Ji T, He Q, Zhang J EMBO J. 2024; 43(10):1965-1989.
PMID: 38605224 PMC: 11099042. DOI: 10.1038/s44318-024-00086-5.
Negron-Pineiro L, Wu Y, Popsuj S, Jose-Edwards D, Stolfi A, Di Gregorio A Nat Commun. 2024; 15(1):3025.
PMID: 38589372 PMC: 11001920. DOI: 10.1038/s41467-024-46850-3.
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Nguyen V, Tessema M, Weissman B Cancer Treat Res. 2023; 190:211-244.
PMID: 38113003 DOI: 10.1007/978-3-031-45654-1_7.
Cheng C, Cong Q, Liu Y, Hu Y, Liang G, Dioneda K Sci Adv. 2023; 9(24):eadf6927.
PMID: 37315133 PMC: 10266736. DOI: 10.1126/sciadv.adf6927.